Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 5.78-7.7120.295.8813.61

What is the latest Core EBITDA Growth ratio of LINCOLN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of LINCOLN PHARMACEUTICALS is 5.78 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar20265.78
Mar2025-7.71
Mar202420.29
Mar20235.88
Mar202213.61

How is Core EBITDA Growth of LINCOLN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 5.78
Positive
Mar2025 -7.71
Negative
Mar2024 20.29
245.07
Mar2023 5.88
-56.80
Mar2022 13.61 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,117.0 Cr -1.8% -12.8% 5.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-1.8%

-12.8%

5.3%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses